# FDA Inspection 1237142 - WakeMed IRB - April 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/wakemed-irb/a05e7bad-ca20-44af-9c15-2dd847367ec4
Source feed: FDA_Inspections

> FDA Inspection 1237142 for WakeMed IRB on April 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237142
- Company Name: WakeMed IRB
- Inspection Date: 2024-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1237142 - 2024-04-29](https://www.keypedia.com/records/fda_inspections/wakemed-irb/0e672798-2ba9-4d10-9387-c4acd6e12473)
- [FDA Inspection 1237142 - 2024-04-29](https://www.keypedia.com/records/fda_inspections/wakemed-irb/53ddd242-e8bd-4ead-8635-965c86922fd2)
- [FDA Inspection 993732 - 2016-12-08](https://www.keypedia.com/records/fda_inspections/wakemed-irb/59a59811-dab9-4871-9ea0-25c84a06e3a4)
- [FDA Inspection 784930 - 2012-06-06](https://www.keypedia.com/records/fda_inspections/wakemed-irb/a00b9ed0-56a0-4b68-ac96-5f4f1059a7b5)

Company: https://www.keypedia.com/companies/wakemed-irb/c233e7bb-e2af-4419-be44-36de8aa3353a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d